Castillo, Shara N.

HRN: 18-94-89  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2022
CEFUROXIME 500MG (TAB)
12/16/2022
12/23/2022
ORAL
500mg
BID
Perineorrhaphy; MSAF
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: